LNTH FY 2020 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$339M-2.3% YoY

Gross Profit

$139M40.9% margin

Operating Income

-$4M-1.2% margin

Net Income

-$13M-4.0% margin

EPS (Diluted)

$-0.25

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$4M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$870M

Total Liabilities

$356M

Stockholders' Equity

$514M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$339M	$347M	-2.3%
Gross Profit	$139M	$175M	-20.6%
Operating Income	-$4M	$52M	-108.1%
Net Income	-$13M	$32M	-142.5%